Aim 1 Identifying druggable Targets for potential ARSACS treatment
Aim 2 Characterize pathophysiology for future druggable target development
Duration : 2nd year of the funded project
Dr. Alanna Watt,Department of Biology McGill University Bellini Life Sciences Bldg.
3469 Sir William Osler, Montreal, Quebec Canada H3G 0B1 Office: Rm. 265 | Lab: Rm. 257
Tel: (514)-398-2806; Fax: (514)-398-5069; Email: email@example.com